US Diplomat Nikki Haley Blasts China, Russia For 'Holding The Hand' Of North Korean Leader

Agencies
July 6, 2017

Washington, Jul 6: The top U.S. diplomat to the United Nations blasted Russia and China on Wednesday for "holding the hand" of North Korean leader Kim Jong Un, as the Trump administration struggled to respond to Pyongyang's latest ballistic-missile test.nikki

U.N. Ambassador Nikki Haley chided Moscow and Beijing over their opposition to a Security Council resolution condemning North Korea and imposing greater economic sanctions for what she called its "sharp military escalation."

She also said Pyongyang was "quickly closing off the possibility of a diplomatic solution" and suggested the United States would continue to consider military action if necessary.

"One of our capabilities lies with our considerable military forces," Haley said during a Security Council meeting in New York. "We will use them if we must, but we prefer not to have to go in that direction."

Haley's pointed speech marked the latest effort by the Trump administration to rally allies and rivals around a common agenda to blunt North Korea's progress, days after Kim's regime tested an intercontinental ballistic missile with a range that experts said would put it within reach of Alaska.

But her remarks also illustrated the limits of the White House's options and lacked specifics about what concrete steps the administration is considering. The missile test marks a new level of advancement in Kim's pursuit of a nuclear weapon that could strike the continental United States. Analysts said a military confrontation could escalate quickly into a mass-casualty war on the Korean Peninsula and Japan, where the United States has stationed tens of thousands of troops.

The standoff cast a shadow as President Donald Trump prepared for his first meeting with Russian President Vladimir Putin and his second with Chinese President Xi Jinping on the sidelines of the Group of 20 summit, which opens Friday in Hamburg. Trump also will meet with Japanese Prime Minister Shinzo Abe and the heads of U.S. allies Britain and Germany.

"We've been pretty consistent that we are never going to broadcast next steps," deputy White House press secretary Sarah Huckabee Sanders told reporters aboard Air Force One as the president traveled to a short stop in Warsaw on Wednesday.

Before leaving Washington, Trump revealed more frustration with Xi, whom he has personally lobbied to enact sanctions on Chinese banks that do business with North Korean companies. The U.S. Treasury Department announced last week that it would block the Bank of Dandong, along the border region between China and North Korea, from accessing U.S. markets. Officials said was the first of potentially greater sanctions by the United States.

On Twitter, Trump wrote: "Trade between China and North Korea grew almost 40% in the first quarter. So much for China working with us - but we had to give it a try!"

Chinese data released in April showed China's trade with the North grew 37.4 percent during the first three months of the year compared with the same period in 2016. China said then that overall trade grew even as it complied with U.N. sanctions and stopped buying North Korean coal.

Russian and Chinese diplomats used the U.N. Security Council meeting to push their joint proposal for a suspension of North Korean nuclear and missile testing in exchange for a suspension of U.S. and South Korean military exercises. Both countries also condemned the U.S. antimissile system being deployed in South Korea and called for it to be removed.

Early Wednesday in Asia, U.S. and South Korean forces fired missiles, conducting joint military exercises that the U.S. Pacific Command cast as a show of "ironclad" resolve.

Daniel Pinkston, a lecturer in international relations at Troy University in Seoul, said he saw no chance Washington and Seoul would agree to halt joint exercises, calling it "a non-starter."

During the U.N. meeting, a Russian official questioned whether North Korea's missile was an ICBM, suggesting it was an intermediate-range weapon.

That prompted Haley to request a second turn at the microphone, during which she said: "If you see this as a threat, if you see this for what it is, which is North Korea showing its muscle, then you need to stand strong. If you chose not to, we will go our own path."

Danny Russel, who served as senior Asia director at the National Security Council under President Barack Obama, said Trump has a "rare blue moon" opportunity this week to meet with and rally the major players - China and Russia on one side and Japan and South Korea on the other - toward some sort of unified display of condemnation of North Korea.

"What the administration needs to do is get China and Russia around an approach, even if it is not as testosterone-rich and muscular as the U.S. would like, so that the basic geometry is five on one, not three on three," said Russel, now a diplomat in residence at the Asia Society in New York. "There is no formula, no path forward, other than war, that isn't built on some degree of common cause between Washington and Beijing."

Victor Cha, who served as senior Asia director at the NSC under President George W. Bush, said the U.S. sanctions on the Dandong bank were "a shot across the bow at the Chinese that what is happening is not working for us. It arguably gives [Trump] a stronger position going in" to the meeting with Xi.

The missile the Kim regime launched had been in the works for years. It flew higher and remained in the air longer than previous attempts, in what experts called a milestone for North Korea

South Korean authorities described North Korea's test as a two-stage missile with a range of about 4,300 to 5,000 miles - enough to reach Alaska and other parts of North America.

South Korean Defense Minister Han Min-koo said there is high probability that Pyongyang will stage another nuclear test and noted gains in its efforts to miniaturize a warhead - steps toward developing nuclear-tipped weapons capable of hitting the mainland United States.

Pyongyang's test appeared to catch the United States by surprise. The Pentagon initially mislabeled the activity as a test of an intermediate-range missile before reclassifying it Wednesday as an ICBM with a range of at least 5,500 kilometers.

Navy Capt. Jeff Davis, a Pentagon spokesman, said that the missile "is not one we have seen before" and that it was launched from a site - the Panghyon airfield about 90 miles north of Pyongyang - that has not been used to test missiles before.

He emphasized that North Korea still has a number of steps to meet before a threat to North America is imminent, noting that Pyongyang has not yet demonstrated the ability to mount a nuclear warhead on a ICBM or show the lateral range necessary.

"But clearly, they are working on it," he said.

North Korea successfully test fired an intercontinental ballistic missile July 3. The missile was launched into a steep arc sending it more than 1,700 vertical miles up before beginning its reentry into Earth's atmosphere.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Beijing:  Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Paris, Apr 10: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could be a potential weapon against novel coronavirus, across 50 countries.

The company has already doubled its incremental production capacity on top of the usual production for current indications across its eight hydroxychloroquine manufacturing sites worldwide and is on track to quadruple it by the summer.

"In this global health emergency, Sanofi stands ready to assist as many countries as possible, starting with countries where its medicine is registered for current approved indications as well as countries where there are no hydroxychloroquine suppliers or countries with underserved populations," it said in a statement.

Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.

"The COVID-19 pandemic is an unprecedented health and economic crisis which is shaking some of the very fundamentals of international solidarity and cooperation among countries," said Chief Executive Officer Paul Hudson. "This virus does not care about the concept of borders, so we should not either," he added.

"It is critical that international authorities, local governments, manufacturers and all other players involved in the hydroxychloroquine chain work together in a coordinated manner to ensure all patients who may benefit from this potential treatment can access it. If the trials prove positive, we hope our donation will play a critical role for patients," said Hudson.

While hydroxychloroquine is generating a lot of hope for patients around the world, said Sanofi, it should be remembered that there are no results from ongoing studies and the results may be positive or negative.

To date, there is insufficient clinical evidence to draw any conclusion over the safety and efficacy of hydroxychloroquine in the management of COVID-19 patients.

It is one of several medicines being investigated by the World Health Organisation (WHO) in its international clinical trial seeking a treatment solution for COVID-19. "Sanofi is supporting ongoing trials by providing the medicine to some participating investigator sites and other independent research centres," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 27,2020

Washington, Feb 27: President Donald Trump has said that the US' relationship with India is "extraordinary" right now and a lot of progress was made in bilateral ties during his maiden official visit to the country where America will be doing a lot of business.

Talking to reporters, after his return from India on Wednesday, Trump said, "He (Prime Minister Narendra Modi) is a great gentleman, a great leader. It's an incredible country."

President Trump visited India from February 24 to 25. He was accompanied by first lady Melania Trump, daughter Ivanka Trump, son-in-law Jared Kushner and the top brass of his administration, including national security advisor Robert O'Brien.

They visited Ahmedabad, Agra and New Delhi before leaving for Washington on Tuesday.

During his stay, he addressed a massive rally in Ahmedabad, visited Agra and held official meetings in New Delhi.

The US President was feted at the world's largest cricket stadium in the "Namaste Trump" event in Ahmedabad and was cheered by tens of thousands of people.

"We were treated very, very well and we really enjoyed it. A lot of tremendous progress was made in terms of relationship - our relationship with India is extraordinary right now," he said.

"We are going to be doing a lot of business with India, they are sending billions and billions of dollars now to the United States," Trump said in response to a question.

In a tweet, his daughter Ivanka said that, Trump announced that US international development finance corporation "will establish a permanent presence in India to strengthen our economic ties, improve development plus further women's economic empowerment through WGDP (Women's Global Development and Prosperity Initiative)!"

On her arrival from India, she thanked PM Modi for "your warm hospitality as we visited your beautiful country and celebrated the strength, spirit and unity of the US and India!"

"Throughout our visit we saw monumental achievements of human creativity and proof of the infinite capacity of the human heart!" she said.

The first lady tweeted two pictures of her with Trump facing the Taj Mahal in Agra.

"One of the Seven Wonders of the World, the breathtaking Taj Mahal!" she said.

President Trump "reaffirmed the strong strategic partnership, vibrant economic ties and expanding security relationship between our two countries. Wonderful trip, but glad to be home! Thank you India!" said White House press secretary Stephanie Grisham.

During the visit, India and the US on Tuesday finalised defence deals worth $3 billion under which 30 military helicopters will be procured from two American defence majors for Indian armed forces.

The deals will include procurement of 24 MH-60 Romeo helicopters by India from the US at a cost of $2.6 billion. Another contract to acquire six AH-64E Apache helicopters for $800 million from the US is also on the table.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.